Quick reference guide to apixaban

Katherine Victoria HurstNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK

John Matthew O’CallaghanNuffield Department of Surgical Sciences, University of Oxford, Oxford, UK

Ashok HandaNuffield Department of Surgical Sciences, University of Oxford, Oxford, UKCorrespondence[email protected]

Pages 263-267 | Published online: 10 Jul 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

HalvorsenSAtarDYangHEfficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trialEur Heart J201435281864187224561548
PubMed Web of Science ®Google Scholar
FlakerGEzekowitzMYusufSEfficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: results from the RE-LY (randomized evaluation of long-term anticoagulation therapy) studyJ Am Coll Cardiol201259985485522361407
PubMed Web of Science ®Google Scholar
HalperinJLHankeyGJWojdylaDMEfficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF)Circulation2014130213814624895454
PubMed Web of Science ®Google Scholar
AgnelliGBullerHRCohenAAMPLIFY InvestigatorsOral apixaban for the treatment of acute venous thromboembolismN Engl J Med2013369979980823808982
PubMed Web of Science ®Google Scholar
Al-KhatibSMThomasLWallentinLOutcomes of apixaban vs. warfarin by type and duration of atrial fibrillation: results from the ARISTOTLE trialEur Heart J201334312464247123594592
PubMed Web of Science ®Google Scholar
EikelboomJWConnollySJGaoPStroke risk and efficacy of apixaban in atrial fibrillation patients with moderate chronic kidney diseaseJ Stroke Cerebrovasc Dis201221642943522818021
PubMed Web of Science ®Google Scholar
HurstKLeeRHandaAQuick reference guide to the new oral anticoagulantsJ Vasc Surg20166361653165727113315
PubMed Web of Science ®Google Scholar
HeeringaJvan der KuipDAHofmanAPrevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam studyEur Heart J200627894995316527828
PubMed Web of Science ®Google Scholar
HartRGPearceLAAguilarMIMeta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillationAnn Intern Med20071461285786717577005
PubMed Web of Science ®Google Scholar
HylekEMHeldCAlexanderJHMajor bleeding in patients with atrial fibrillation receiving apixaban or warfarin: the ARISTOTLE trial (apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation): predictors, characteristics, and clinical outcomesJ Am Coll Cardiol201463202141214724657685
PubMed Web of Science ®Google Scholar
ConnollySJEikelboomJJoynerCApixaban in patients with atrial fibrillationN Engl J Med2011364980681721309657
PubMed Web of Science ®Google Scholar
NICE [webpage on the Internet]Venous thromboembolism in adults: reducing the risk in hospital2010 Available from https://www.nice.org.uk/guidance/qs3Accessed June 13, 2017
Google Scholar
LassenMRGallusARaskobGEApixaban versus enoxaparin for thromboprophylaxis after hip replacementN Engl J Med2010363262487249821175312
PubMed Web of Science ®Google Scholar
LassenMRRaskobGEGallusAPineoGChenDHornickPADVANCE-2 investigatorsApixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trialLancet2010375971780781520206776
PubMed Web of Science ®Google Scholar
MandernachMWBeythRJRajasekharAApixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based reviewTher Clin Risk Manag2015111273128226345156
PubMed Web of Science ®Google Scholar
GoldhaberSZBounameauxHPulmonary embolism and deep vein thrombosisLancet201237998281835184622494827
PubMed Web of Science ®Google Scholar
Idarucizumab (praxbind) – an antidote for dabigatranMed Lett Drugs Ther201557148215715826583604
PubMed Web of Science ®Google Scholar
KeelingDCotterFManagement of bleeding in patients taking FXa and FIIa inhibitorsBr J Haematol201316011223110431
PubMed Web of Science ®Google Scholar
BauersachsRBerkowitzSDBrennerBOral rivaroxaban for symptomatic venous thromboembolismN Engl J Med2010363262499251021128814
PubMed Web of Science ®Google Scholar
BüllerHRPrinsMHLensinAWEINSTEIN–PE InvestigatorsOral rivaroxaban for the treatment of symptomatic pulmonary embolismN Engl J Med2012366141287129722449293
PubMed Web of Science ®Google Scholar
PicciniJPHellkampASLokhnyginaYRelationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trialJ Am Heart Assoc201432e00052124755148
PubMed Web of Science ®Google Scholar
SchulmanSKearonCKakkarAKRE-COVER Study GroupDabigatran versus warfarin in the treatment of acute venous thromboembolismN Engl J Med2009361242342235219966341
PubMed Web of Science ®Google Scholar
RuffCTGiuglianoRPAntmanEMEvaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the effective aNticoaGulation with factor xA next generation in atrial fibrillation-thrombolysis in myocardial infarction study 48 (ENGAGE AF-TIMI 48)Am Heart J2010160463564120934556
PubMed Web of Science ®Google Scholar
SaidKHokusai-VTE: edoxaban for the treatment of venous thromboembolismGlob Cardiol Sci Pract20132013441642024749116
PubMedGoogle Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Quick reference guide to apixaban

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Quick reference guide to apixaban

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date